Status:
RECRUITING
Polycystic Kidney Disease Data Repository
Lead Sponsor:
The Rogosin Institute
Collaborating Sponsors:
Weill Medical College of Cornell University
New York Presbyterian Hospital
Conditions:
Polycystic Kidney Disease
Eligibility:
All Genders
18+ years
Brief Summary
Autosomal dominant polycystic kidney disease (PKD) is the most common inherited kidney disease, affecting more than 400,000 people in the U.S. and 5 million people worldwide. PKD is the 4th most commo...
Detailed Description
Visit #1: * An initial detailed history, physical examination, and laboratory evaluation * An extensive family history of PKD will be obtained from the patient. Follow-up Study Visits: \- Patients ...
Eligibility Criteria
Inclusion
- Any person, age 18 or older, with previously diagnosed ADPKD is eligible to participate.
Exclusion
- Inability to provide informed consent.
Key Trial Info
Start Date :
November 1 2002
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2030
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT00792155
Start Date
November 1 2002
End Date
December 1 2030
Last Update
November 12 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Rogosin Institute
New York, New York, United States, 10021